He started a course with his PT, which continued in parallel
Future research should further verify its efficacy and safety in humans, and optimize its formulation and administration methods, providing new options for the treatment of burns, trauma, diabetic ulcers and inflammatory bowel disease
(RFK Jr.) discussed the FDAs current restrictions on peptides, stating his intention was to make peptides more accessible
(OUP Academic) What it doesnt do (important for expectations) AOD-9604 is not designed to: strongly suppress appetite, slow gastric emptying, meaningfully lower A1c by itself
This means healing materials, oxygen, nutrients, and growth factors delivered through blood struggle to reach the exact area where damage occurs